POAS Stock: Phaos Technology Holdings (Caym Stock Price, Analysis & Insights
Get live poas stock price $3.70, comprehensive Phaos Technology Holdings (Caym stock analysis, charts, news, and expert forecast. Real-time poas stock data and investment insights.
Loading chart...
Company Overview
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
Company Information
- CEO
- Sian Yeo
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 25
Contact Information
- Website
- https://phaostech.com
- Address
- 83 Science Park Dr
- Country
- SG
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.00) may provide portfolio stability
Business Model & Strategy
Phaos Technology Holdings (Caym operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Sian Yeo, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Phaos Technology Holdings (Caym competes in the Medical - Devices within the broader Healthcare. With 49.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange Arca, Phaos Technology Holdings (Caym provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Phaos Technology Holdings (Caym should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Phaos Technology Holdings (Caym shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Phaos Technology Holdings (Caym
- ⚠Investors should consider how Phaos Technology Holdings (Caym fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
49.22M
P/E Ratio
-12.33
Beta
0.00
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 49.22M market capitalization
- Trading Volume: 351.65K shares traded today
- Price Range: 52-week range of $2.98 - $4.30
- Exchange: Listed on New York Stock Exchange Arca
Financial Metrics
Market Analysis for Phaos Technology Holdings (Caym
Phaos Technology Holdings (Caym (POAS) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 49.22M, the company represents a significant player in its market. The stock is currently trading at $3.70 with a negativedaily change of 0.54%.
The company's 25 employee base and presence on the New York Stock Exchange Arcaexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -12.33, beta of 0.00, and 52-week price range from $2.98 to $4.30when evaluating investment opportunities.
Why Invest in Phaos Technology Holdings (Caym?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange Arca)
- • Experienced leadership under Sian Yeo
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.